United States · FDA National Drug Code directory
Carbamazepine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51672-4123_5a4a48b3-c961-591d-e063-6394a90ab81d
- Product NDC
- 51672-4123
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Carbamazepine
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20090331
- Source listing expiry
- 20271231
Source-listed ingredients
- CARBAMAZEPINE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4123-1) · 51672-4123-1
- 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4123-3) · 51672-4123-3
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4123-6) · 51672-4123-6
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →